Novo Nordisk Research Centre Oxford is an innovative target discovery unit with a focus on identifying novel, game-changing therapies for patients with type 2 diabetes and cardiometabolic diseases.
We employ advanced computational biology, state-of-the-art discovery screening technologies, genetics and human-centric cell systems to dissect pathophysiology and identify novel drug targets. The site is a fusion of the best of academia, biotech and big pharma in order to realize cutting-edge biology and start a target’s journey from bench to bedside.
NNRCO operates at the boundaries of frontier science with a mandate to find dynamic, agile and distinctive new ways of working to diversify the company’s pipeline with disruptive medicines.
Our Research Centre Oxford continuously looks for partners with expertise in type 2 diabetes and cardiometabolic diseases, from novel modalities to technologies, in early research to clinical stage.
We are interested in academic and industrial partners who use disruptive technologies to challenge traditional ways of thinking and benefit unmet patient needs. We offer partners our disease understanding, human-centric scientific models, state-of-the-art technologies and tailored collaborations.
Contact us to engage with us: NNRCOinfo@novonordisk.com.
We describe ourselves as collaborative, dedicated and ambitious, with an innovative science-oriented approach to drive change to improve patient’s lives. We are a diverse group with backgrounds in bioinformatics, genetics, disease biology, technology and drug discovery.
Our workplace values and culture are spelled out in The Novo Nordisk Way.
Visit our careers page to find opportunities to join our team.
Our Oxford Fellowship Programme is run in close collaboration with the University of Oxford.
The programme supports the development of the next generation of exceptional researchers, advancing scientific discovery in diabetes, obesity, cardiovascular disease, rare blood disorders, and other cardiometabolic disorders.
We have approximately four highly competitive research training postdoctoral fellowship positions available each year.
Visit the Oxford Fellowship Programme website for open positions and to learn more about current and past fellows.
Novo Nordisk’s relationship with the University of Oxford started with Novo Nordisk being one of the founding partners for the Oxford Centre for Diabetes, Endocrinology and Metabolism. The current fellowship programme with the University of Oxford was later established, before our strategic alliance with the University of Oxford started, as well as the establishment of our Research Centre Oxford.
The joint ambition for the research centre is to combine our experience in developing treatments for diabetes with the expertise of renowned scientists from the University of Oxford.
Teams at Research Centre Oxford work together to solve complex scientific challenges using human genetics, big data and cutting-edge technologies. The Oxford site drives in house discovery efforts with external collaborators, in partnership with other Novo Nordisk international sites. The global collaboration contributes to our overall pipeline and to greater scientific understanding to help solve unmet needs in the diabetes and cardiometabolic fields.
